Showcasing Purpose-built Research Sites and Commitment to Inclusive, Patient-focused Clinical Trials at Booth #608
Schedule a meeting with Paradigm Clinical Research’s experts and discover how our dedicated team delivers tailored patient recruitment, enrollment, and retention solutions to support the success of your studies.
About DIA 2025 Global Annual Meeting
DIA 2025, held June 15–19 in Washington, DC, brings together thousands of professionals across life sciences, healthcare, and regulatory sectors. With more than 200 sessions across 12 content tracks, Global Executive Day, expanded regulatory town halls, and new Spotlight Sessions, DIA 2025 serves as a critical platform for advancing collaboration and innovation to improve patient outcomes worldwide.
REDDING, Calif.; May 6, 2025 – Paradigm Clinical Research, a leading clinical research site business, today announced it will exhibit at the DIA 2025 Global Annual Meeting (DIA 2025), taking place June 15-19 in Washington, DC.
DIA 2025 is the ultimate global gathering for industry pioneers, regulatory experts, and healthcare visionaries. This flagship event is more than just a conference, it’s a catalyst for change, bringing together the brightest minds from across the globe to shape the future of healthcare, drug development, and regulatory science. Paradigm will be exhibiting at booth #608, where attendees can learn how its wholly owned, purpose-built clinical research sites, supported by experienced partner investigators, deliver exceptional value in both patient and healthy volunteer studies.
“We’re excited to connect with the global life sciences community at DIA,” said Kurt Mussina, CEO at Paradigm Clinical Research. “This event is an ideal forum to share how our purpose-built research sites and focus on diverse patient populations are driving successful outcomes and more inclusive clinical trials.”
Attendees can visit Paradigm Clinical Research at booth #608 to learn how the company is advancing patient outcomes by prioritizing patient needs, increasing access to underrepresented populations, and accelerating new therapy development through high-quality, efficient clinical trials.
Schedule a meeting to connect with Paradigm Clinical Research at DIA 2025.
About Paradigm Clinical Research
Paradigm Clinical Research is a long-standing clinical research site business with purpose-built research sites located in California, Colorado and Idaho. The company operates wholly owned sites that support Phase I-IV clinical trials and provides sponsors with access to diverse and often underrepresented patient populations and investigators. Paradigm’s mission is to enrich lives by offering opportunities to advance the human condition through participation in expertly conducted clinical trials.